Identification and Characterization of a Novel Form of the Human L-Dopa Decarboxylase mRNA

被引:0
|
作者
Dido Vassilacopoulou
Diamantis C. Sideris
Alice G. Vassiliou
Emmanuel G. Fragoulis
机构
[1] University of Athens,Department of Biochemistry
来源
Neurochemical Research | 2004年 / 29卷
关键词
alternative splicing; coding region; human; L-Dopa decarboxylase; mRNA; 5′-untranslated region;
D O I
暂无
中图分类号
学科分类号
摘要
L-Dopa decarboxylase (DDC) has been cloned from several species and was shown to undergo alternative splicing within its 5′-untranslated and coding regions. In this report we describe a novel splice variant of DDC mRNA in human tissue, lacking exons 10 - 15 of the full-length transcript but including an alternative exon 10. The isolated alternative human DDC cDNA (alt-DDC) was cloned from human placenta, and was found to be of the neuronal type. Northern blot analysis indicated that the alt-DDC transcript is expressed in high levels in human kidney. Our results demonstrate the detection of a new alternative splicing event within the coding region of the human DDC mRNA, further suggesting that the single copy human DDC gene undergoes complex processing leading to the formation of multiple mRNA isoforms.
引用
收藏
页码:1817 / 1823
页数:6
相关论文
共 50 条
  • [31] INTERACTIONS OF METAL CHELATED L-DOPA WITH PYRIDOXAL-PHOSPHATE AND THEIR SIGNIFICANCE IN THE INHIBITION OF L-DOPA DECARBOXYLASE
    RAJAN, KS
    DAVIS, JM
    [J]. PHARMACOLOGIST, 1979, 21 (03): : 171 - 171
  • [32] Purification of an endogenous inhibitor of L-Dopa decarboxylase activity from human serum
    Vassiliou, AG
    Vassilacopoulou, D
    Fragoulis, EG
    [J]. NEUROCHEMICAL RESEARCH, 2005, 30 (05) : 641 - 649
  • [33] L-DOPA INFUSION EXPERIMENTS IN COMBINATION WITH THE L-DOPA-DECARBOXYLASE INHIBITORS BENSERAZIDE AND CARBIDOPA - L-DOPA METABOLISM AND NEUROENDOCRINOLOGICAL EFFECTS
    KAPFHAMMER, HP
    KUSS, HJ
    EBEN, E
    RUTHER, E
    [J]. PHARMACOPSYCHIATRY, 1985, 18 (01) : 143 - 144
  • [34] Expression of Human L-Dopa Decarboxylase (DDC) under Conditions of Oxidative Stress
    Lotsios, Nikolaos S.
    Arvanitis, Nikolaos
    Charonitakis, Alexandros G.
    Mpekoulis, George
    Frakolaki, Efseveia
    Vassilaki, Niki
    Sideris, Diamantis C.
    Vassilacopoulou, Dido
    [J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (12) : 10179 - 10192
  • [35] L-DOPA Decarboxylase Association with Membranes in Mouse Brain
    Poulikos Poulikakos
    Dido Vassilacopoulou
    Emmanuel G. Fragoulis
    [J]. Neurochemical Research, 2001, 26 : 479 - 485
  • [36] L-DOPA decarboxylase association with membranes in mouse brain
    Poulikakos, P
    Vassilacopoulou, D
    Fragoulis, EG
    [J]. NEUROCHEMICAL RESEARCH, 2001, 26 (05) : 479 - 485
  • [37] STUDIES ON INHIBITION OF L-DOPA DECARBOXYLASE INVITRO AND INVIVO
    CLARK, WG
    [J]. PHARMACOLOGICAL REVIEWS, 1959, 11 (02) : 330 - 349
  • [38] TREATMENT OF PARKINSONS DISEASE WITH L-DOPA AND DECARBOXYLASE INHIBITOR
    RINNE, UK
    SONNINEN, V
    SIIRTOLA, T
    [J]. ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (01): : 1 - &
  • [39] Human L-Dopa decarboxylase interaction with annexin V and expression during apoptosis
    Chalatsa, Ioanna
    Arvanitis, Nikolaos
    Arvanitis, Dimitrios
    Tsakou, Anastasia C.
    Kalantzis, Evangelos D.
    Vassiliou, Alice G.
    Sideris, Diamantis C.
    Frakolaki, Efseveia
    Vassilaki, Niki
    Vassilacopoulou, Dido
    [J]. BIOCHIMIE, 2020, 177 : 78 - 86
  • [40] Purification of an Endogenous Inhibitor of L-Dopa Decarboxylase Activity from Human Serum
    Alice-Georgia Vassiliou
    Dido Vassilacopoulou
    Emmanuel G. Fragoulis
    [J]. Neurochemical Research, 2005, 30 : 641 - 649